Falchi, L., Baron, J. M., Orlikowski, C. A., & Ferrajoli, A. (2016). BCR Signaling Inhibitors: An Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia. Mediterr J Hematol Infect Dis.
Chicago-стиль цитированияFalchi, Lorenzo, Jessica M. Baron, Carrie Anne Orlikowski, and Alessandra Ferrajoli. "BCR Signaling Inhibitors: An Overview of Toxicities Associated With Ibrutinib and Idelalisib in Patients With Chronic Lymphocytic Leukemia." Mediterr J Hematol Infect Dis 2016.
MLA-цитированиеFalchi, Lorenzo, Jessica M. Baron, Carrie Anne Orlikowski, and Alessandra Ferrajoli. "BCR Signaling Inhibitors: An Overview of Toxicities Associated With Ibrutinib and Idelalisib in Patients With Chronic Lymphocytic Leukemia." Mediterr J Hematol Infect Dis 2016.